Phase II study of a combination of iIrinotecan and S-1 in patients with advanced gastric cancer (OGSG0002)

Uedo, N., Naraha, H., Ishihar,R. Takiuchi, H., Goto, M., Fujitani, K., Hirao, M., Tsujinaka, T. Imano, M., Furukawa, H., Tsukuma, H., and Taguchi, T. Phase II study of a combination of iIrinotecan and S-1 in patients with advanced gastric cancer (OGSG0002), Oncology, 73, 65?71.